Skip to main content
. 2023 Sep 11;6(9):e2332568. doi: 10.1001/jamanetworkopen.2023.32568

Table 2. Between-Group Difference in SIV Uptake and SOC at Month 6.

Outcome Participants, No. (%) P value
Intervention group Control group
Complete case analysis
Total participants 174 165 NA
SIV uptake: yes 100 (57.5) 70 (42.4) .006
SOC at month 6
Precontemplation stage 58 (33.3) 73 (44.2) NA
Contemplation stage 16 (9.2) 17 (10.3) NA
Preparation stage 0 5 (3.0) NA
Action stage 100 (57.5) 70 (42.4) .008
SOC score, mean (SD)a 2.8 (1.4) 2.4 (1.4) .01
Changes in SOC score from baseline to month 6, mean (SD)a 0.7 (1.0) 0.4 (1.0) .048
Intention-to-treat analysis
Total participants 198 198 NA
SIV uptake: yes 100 (50.5) 70 (35.3) .002
SOC at month 6
Precontemplation stage 68 (34.3) 88 (44.4) NA
Contemplation stage 18 (9.1) 21 (10.6) NA
Preparation stage 0 (0) 9 (4.5) NA
Action stage 112 (56.6) 80 (40.4) .001
SOC score, mean (SD)a 2.8 (1.4) 2.4 (1.4) .02
Changes in SOC score from baseline to month 6, mean (SD)a 0.7 (1.0) 0.5 (1.0) .04

Abbreviations: NA, not applicable; SIV, seasonal influenza vaccination; SOC, stage of change.

a

1 = Precontemplation stage, 2 = contemplation stage, 3 = preparation stage, and 4 = action stage. The χ2 tests were used to compare SIV uptake and SOC between the intervention group and the control group. Independent-sample, unpaired, 2-tailed t test was used to compare the SOC score and changes in the SOC score between the intervention group and the control group.